RT Journal Article
SR Electronic
T1 Clinical epidemiology of pneumonia in hemodialysis patients
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP P576
VO 40
IS Suppl 56
A1 Jae Ho Chung
A1 Chang Hoon Han
YR 2012
UL http://erj.ersjournals.com/content/40/Suppl_56/P576.abstract
AB Introduction: Traditionally, pneumonia developing in patients who receive health care services in the outpatient environment, such as nursing homes, long-term care facilities, and dialysis centers, has been classified and treated as community-acquired pneumonia (CAP). A greater recognition of HCAP as a new class of pneumonia with a distinct epidemiologic, microbiologic, and clinical profile should lead physicians to initiate appropriate empiric antibiotic therapy more often, thereby improving the likelihood for optimal clinical outcomes and patient care.Method: Among the HCAP, we inspect the retrospective to identify hospitalizations with pneumonia in 218 hemodialysis patients between Jan 2010 and Dec 2011 at Myongji and National Health Insurance Corporation Ilsan Hospital.Results: Mean patient age was 60.3 years and duration of end-stage renal disease (ESRD) 3.8 years; 41.1% of patients had diabetes mellitus. From the associated microbiological spectrum, no organism was specified in 71.7% of cases; 16.1% (35 patients) of cases were attributed to gram-positive bacteria, 13.3% (29 patietnts) to gram-negative bacteria and 9.2% (15 patients) cases were drug resistant organism (methicillin resistant S.aureus: 13 patients, ESBL K.pneumonia: 2 patietns). We treated 218 patients with pneumonia treatment guidelines. Among the 218 ESRD pneumonia patients, 8.7% (19 patients) received mechanical ventilation and 3.2%(7 patients) were died.Conclusion: Although ESRD patients suffered from pneumonia caused by multi-drug resistant pathogens compared with previous CAP studies, including S. aureus, their pneumonia mortality was not serious compared with previous CAP studieds.